Immunogenomic features of pathologic response to neoadjuvant immune checkpoint blockade in esophageal cancer.

Zineb Belcaid,Archana Balan,Christopher Cherry,Mara Lanis,Kristen A. Marrone,Benjamin Levy,Heather Schneider,Hanika Rodavia,Blair A. Jobe,Elizabeth D. Thompson,Victor E. Velculescu,Richard J. Battafarano,Stephen C. Yang,Stephen R. Broderick,Jinny Ha,Ali H. Zaidi,Ronan J. Kelly,Josephine Feliciano,Valsamo Anagnostou,Vincent K. Lam

Immunogenomic features of pathologic response to neoadjuvant immune checkpoint blockade in esophageal cancer.

2021

4042Background: Improving immunotherapy efficacy remains an unmet need in esophagogastric cancer and a deeper understanding of tumor and immune system dynamics during therapy may tailor immuno-onco...

Keywords:

Internal medicine
Medicine
esophagogastric cancer
unmet needs
Immune checkpoint
Oncology
Pathologic Response
Esophageal cancer
Blockade
Immune system
Immunotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations